Upon hearing about the war on drugs, many of us in medicine immediately become skeptical. Same old, same old—nothing seems to change. Yet this year, new healthcare codes for drug screening and intervention have been developed. Can these new efforts make a difference? Our guest today is Dr. Bertha Madras who serves as the Deputy Director of Demand Reduction in the White House office of National Drug Control Policy. Prior to this government post, she was Professor of Psychobiology in the Department of Psychiatry at Harvard Medical School. She is an expert on drug addiction and has authored over 130 papers and book chapters as well as receiving 16 patents.
War on Drugs: New CPT codes for screening and RX
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Recommended
Details
Presenters
Overview
Upon hearing about the war on drugs, many of us in medicine immediately become skeptical. Same old, same old—nothing seems to change. Yet this year, new healthcare codes for drug screening and intervention have been developed. Can these new efforts make a difference? Our guest today is Dr. Bertha Madras who serves as the Deputy Director of Demand Reduction in the White House office of National Drug Control Policy. Prior to this government post, she was Professor of Psychobiology in the Department of Psychiatry at Harvard Medical School. She is an expert on drug addiction and has authored over 130 papers and book chapters as well as receiving 16 patents.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
0.25 credits
<p>Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy</p>
CME/CE
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
0.50 credits
<p>IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement</p>
CME/CE
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
0.50 credits
<p>IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
CME/CE
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
0.25 credits
<p>IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy</p>
MinuteCE®
Diagnosis and Management of Metastatic PDAC
0.25 credits
<p>Diagnosis and Management of Metastatic PDAC</p>
CME/CE
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
1.00 credits
<p>Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers</p>
CME/CE
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
<p>FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?